Here, by systematic characterization of STING pathway in SCLC, we found that the STING‐high subtype is associated with more abundant immune infiltrates, while the STING‐low subtype exhibits higher NE score and the enrichment of cell cycle pathways. Here, STING1 is linked to small cell lung carcinoma.